Schonfeld Strategic Advisors LLC Rx Sight, Inc. Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$50.42 - $64.29 $5.85 Million - $7.46 Million	-116,102 Reduced 70.75%	48,004 $2.89 Million
Q1 2024 May 15, 2024	SELL	$35.51 - $57.92 $880,257 - $1.44 Million	-24,789 Reduced 13.12%	164,106 $8.46 Million
Q4 2023 Feb 14, 2024	BUY	$20.91 - $40.9 $1.67 Million - $3.27 Million	79,995 Added 73.46%	188,895 $7.62 Million
Q3 2023 Nov 14, 2023	SELL	$27.05 - $33.37 $1.03 Million - $1.27 Million	-38,000 Reduced 25.87%	108,900 $3.04 Million
Q2 2023 Aug 14, 2023	BUY	$16.37 - $28.9 $384,695 - $679,150	23,500 Added 19.04%	146,900 $4.23 Million
Q1 2023 May 15, 2023	BUY	$12.58 - $16.68 $951,048 - $1.26 Million	75,600 Added 158.16%	123,400 $2.06 Million
Q4 2022 Feb 14, 2023	BUY	$9.93 - $14.2 $474,654 - $678,760	47,800 New	47,800 $605,000

225

32.3M

394K

32K

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.27B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.